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Background: Despite significant investment in infrastructure many trials continue to face challenges in recruitment
and retention. We argue that insufficient focus has been placed on the development and testing of recruitment
and retention interventions.
Methods: In this current paper, we summarize existing reviews about interventions to improve recruitment and
retention. We report survey data from Clinical Trials Units in the United Kingdom to indicate the range of interventions
used by these units to encourage recruitment and retention. We present the views of participants in a recent
workshop and a priority list of recruitment interventions for evaluation (determined by voting among workshop
participants). We also discuss wider issues concerning the testing of recruitment interventions.
Results: Methods used to encourage recruitment and retention were categorized as: patient contact, patient
convenience, support for recruiters, monitoring and systems, incentives, design, resources, and human factors.
Interventions felt to merit investigation by respondents fell into three categories: training site staff, communication
with patients, and incentives.
Conclusions: Significant resources continue to be invested into clinical trials and other high quality studies, but
recruitment remains a significant challenge. Adoption of innovative methods to develop, test, and implement
recruitment interventions are required.
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There is currently a worldwide drive to enhance health,
wellbeing, and wealth through effective research and
dissemination. In the United Kingdom, the overarching
vision of the National Institute for Health Research
(NIHR) is to see ‘more patients and health professionals
participating in health research’ [1].
A critical part of the health research portfolio is the
testing of interventions through randomized controlled
trials. Trials can range from highly controlled explana-
tory trials through to pragmatic trials of new health* Correspondence: peter.bower@manchester.ac.uk
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unless otherwise stated.technologies and models of service delivery. A large
number of trials are dependent on the willingness of
patients and professionals to give their time and effort
to participate. If high levels of participation (through
recruitment to the study and longer-term retention) are
not achieved, this has implications for statistical power,
internal validity, and external validity. Recruitment prob-
lems also have practical and financial impacts, as they
can delay completion of research or reduce its timely
impact on patient health and wellbeing.
Achieving appropriate levels of patient and profes-
sional participation has been a significant obstacle to
evidence-based practice. Published data show that the
minority of trials recruit successfully, either in terms of
reaching their planned sample size, or delivering the
planned sample in the expected recruitment windowLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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these initial surveys, related in part to the significant
investment in infrastructure [4], problems still remain
[5]. A recent survey of Clinical Trials Units (CTUs) in
the United Kingdom conducted by the some of the
authors [6] found that recruitment remained the number
one priority of those units.
A recent review outlined three core areas of relevance
in improving recruitment and retention: infrastructure
(for example networks, resources, and information tech-
nology), professional and public engagement with re-
search, and methodological innovation (the development
of an evidence base around effective methods of recruit-
ment) [7]. This current paper is designed to provide an
overview of the current knowledge and practice in the
area of methodological innovation, in order to set out a
clear research agenda for the future.
Methodological innovation
Many insights into the recruitment and retention process
have been generated from qualitative case studies con-
ducted alongside existing trials [8-11], as well as research
on hypothetical situations [12,13]. However, translating
those insights into enduring and generalizable impacts on
recruitment is not straightforward. Although this may be
due to other limitations in the academic literature (such
as the lack of robust theory to guide intervention develop-
ment), the limited impact of this work may in part reflect
the fact that these (essentially post hoc) explanations of
recruitment processes are rarely subjected to formal
examination in prospective studies. From the perspective
of the principal investigator struggling with recruitment
problems, this research has generated hypotheses to be
tested rather than proven levers to ease recruitment.
The most robust test of the effectiveness of a recruit-
ment or retention method is a trial comparing one
recruitment method with an alternative, ‘nested’ within
an ongoing trial being conducted in routine settings. By
‘nesting’, we refer to patients being randomly allocated to
two or more alternative methods of recruitment. For
example, a published study randomly allocated patients
to an opt-in (where they were asked to actively signal
willingness to participate in research) or opt-out method
(where they were contacted repeatedly unless they stated
unwillingness to participate) [14]. Such studies allow a
less biased and more externally valid assessment of the
effectiveness of a recruitment intervention. Nevertheless,
despite the vast amount of activity in the area of clinical
trials, nested studies of recruitment interventions remain
very rare [15-17].
In this paper, we draw on a number of sources of data
(including existing reviews on recruitment and retention
interventions, survey data from CTUs in the United
Kingdom, and views of participants in a recruitmentworkshop) to meet the following aims: to summarize
knowledge about interventions to improve recruitment
and retention, to indicate the range of interventions used
by CTUs in the United Kingdom, to present a priority
list of recruitment and retention interventions for evalu-
ation, and to consider wider issues concerning the testing
of recruitment interventions.
Summary of current knowledge on recruitment and
retention
Interventions to improve recruitment have been the focus
of a number of systematic reviews. A Cochrane review
collated randomized and quasi-randomized controlled
trials of interventions to increase recruitment to trials,
including those recruiting to hypothetical studies [15,16].
The review included 45 trials involving 46 interventions
and over 43,000 participants. Some interventions were
effective in increasing recruitment, such as telephone re-
minders to non-respondents (risk ratio (RR) 1.66, 95% CI
1.03 to 2.46), use of opt-out rather than opt-in procedures
for contacting potential participants (RR 1.39, 95% CI 1.06
to 1.84), and open designs whereby participants know
which treatment they are receiving in the trial (RR 1.22,
95% CI 1.09 to 1.36). A substantial problem noted by the
reviewers was the tendency for investigators to evaluate
new interventions that are unlike earlier interventions,
making pooling data difficult. This has resulted in a large
pool of relatively unique recruitment interventions of
uncertain benefit. Other reviews [18,19] came to similar
conclusions, although one review found no evidence that
strategies aiming to increase understanding of the trial
process improved recruitment, but did find some support
for strategies that increased understanding of the health
problem being studied [18].
Fletcher et al. [20] focused on strategies aimed at in-
creasing the recruitment activity of clinicians and found
eight quantitative studies, only three of which were tri-
als. One trial looked at the effect of using nurses rather
than surgeons to recruit participants and found that this
had little or no effect (RR 0.94, 95% CI 0.76 to 1.17),
though it was more cost-effective. There was limited
evidence that greater communication between central
trial coordinators and trial sites, and on-site monitoring
had no impact on recruitment. The use of qualitative
methods to identify and overcome barriers to clinician
recruitment activity appeared promising, although the
picture was mixed, with impressive improvements at
one centre and no or modest improvements at others.
The approach is certainly worthy of further investiga-
tion. A Cochrane review of incentives and disincentives
to participation in trials by clinicians found no trials of
relevant interventions [21]. The impact of a number of
potential (dis)incentives was explored in observational
studies but none were shown to have a significant
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robust evidence, researchers need to be aware that many
aspects of trial design and conduct might affect clini-
cians’ willingness to invite patients to participate.
In summary, there are some promising strategies for
increasing recruitment to trials. However, some of those
methods (such as open-trial designs and opt-out strat-
egies), must be considered carefully as their use may also
present methodological or ethical challenges. Use of quali-
tative methods to explicitly identify and address barriers
to participation appears promising and warrants greater
evaluation. There is a clear knowledge gap with regard to
effective strategies aimed at recruiters.
Retention strategies have been the subject of three
systematic reviews. Most of the retention strategies
evaluated have focused on improving response to postal
or electronic questionnaires, rather than return to trial
sites to complete face-to-face assessments. A Cochrane
systematic review on methods to increase response to
postal and electronic questionnaires included 513 trials,
with 137 strategies identified [22]. The most effective
strategies to improve postal questionnaire response were:
monetary incentives (odds ratio (OR) 1.87, 95% CI 1.73 to
2.04), recorded delivery (OR 1.76, 95% CI 1.43 to 2.18), a
teaser on the envelope (OR 3.08, 95% CI 1.27 to 7.44) and
having a more interesting questionnaire topic (OR 2.00,
95% CI 1.32 to 3.04). Other communication and question-
naire modification strategies found to be effective were:
including pre-notification reminders, follow-up contact
with participants, shorter questionnaires, and providing a
second copy of a questionnaire. Several effective strategies
for increasing responses to electronic questionnaires were
found which included: including a picture in an email (OR
3.05, 95% CI 1.84 to 5.06), non-monetary incentives (OR
1.72, 95% CI 1.09 to 2.72) and other communication, and
motivational and electronic questionnaire strategies. How-
ever, mentioning ‘Survey’ in the email subject line (OR
0.81, 95% CI 0.67 to 0.97), and emails including a male
signature (OR 0.55, 95% CI 0.38 to 0.80) reduced the odds
of a response. An earlier systematic review also focused
on ways to increase the response to postal questionnaires
in healthcare research [23]. A total of 15 trials were
included in this review. Reminder letters (OR 3.7, 95% CI
2.30–5.97) and shorter questionnaires increased response
(OR 1.4, 95% CI 1.19 to 1.54). Monetary incentives were
not found to be effective.
These reviews were broad and included nested
evaluations of strategies to improve retention in surveys,
cohort studies, and randomized trials. Although some of
the included trials in the reviews were nested in trials,
most were nested in other study designs and the results
may not be directly applicable to trials. A recent system-
atic review examined the effectiveness of strategies to
improve retention in randomized trials specifically, andfound 38 trials that evaluated six different types of strat-
egies [17]. Most of the included trials aimed to improve
questionnaire response. Questionnaire response was im-
proved by actually adding monetary incentives (RR =1.18,
95% CI 1.09 to 1.28), the offer of monetary incentives
(RR =1.25, 95% CI 1.14 to 1.38), and higher value incen-
tives (RR =1.12, 95% CI 1.04 to 1.22). Based on results of
single trials, response was improved by recorded delivery
of questionnaires (RR =2.08, 95% CI 1.11 to 3.87), a
specialized postal strategy (RR =1.43, 95% CI 1.22 to 1.67)
and an open-trial design (RR =1.37, 95% CI 1.16 to 1.63).
There is no clear evidence that questionnaire response or
retention were improved by any of the other incentives,
questionnaire modification, and communication strategies
evaluated including the giving or offering gifts, offering
charity donations, shorter or longer and clear question-
naires, sending questionnaires early, ‘enhanced’ letters (i.e.
letters which contained additional information about trial
processes or which included novel features, such as the
signature of the main investigator), priority post, add-
itional reminders, questionnaire question order, reminders
to sites, and behavioral or case management strategies.
In summary, offering and giving small monetary incen-
tives improves questionnaire response in randomized trials,
while non-monetary incentives and some communication
strategies have shown no effect. Some strategies need
further evaluation, particularly where the results are
based on single trials.
Methods
In the United Kingdom, funding bodies increasingly
require that trials involve a United Kingdom Clinical
Research Collaboration registered CTU to ensure high
quality delivery and appropriate support with ethical,
governance, operational, and methodological issues. Due
to their active involvement with multiple trials, CTU
staff are potentially in an excellent position to provide
an overview of current methods used to stimulate
recruitment and retention.
In order to provide data on current practice, 48 CTU
directors in the United Kingdom were sent an invitation
to an online survey about the methods and practices
currently used by CTUs to improve recruitment and
retention. Directors were asked to identify a member of
staff best placed to provide responses on behalf of the
unit. Where more than one member of staff from the
same CTU completed the survey, similar responses were
combined to ensure that responses from the same CTU
were not counted twice. Respondents were asked about
the methods used to improve recruitment and retention
(with or without formal evaluation), methods which had
been formally evaluated, and recruitment and retention
interventions thought to merit evaluation in the future.
The full list of questions is provided in Additional file 1.
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responses from all CTUs.
The results from the CTUs survey were used to
inform a workshop on interventions to improve recruit-
ment and retention, organized by the Medical Research
Council North West Hub for Trials Methodology Re-
search on behalf of the Medical Research Council Hub
for Trials Methodology Research Network. Attendees at
the workshop (n =45) were predominantly staff from
CTUs (approximately 80%), as well as researchers out-
side CTUs, and representatives from funding agencies
from the United Kingdom. Data from existing Cochrane
reviews (summarized previously) were used alongside
data from the survey to generate discussion around re-
cruitment interventions. The final part of the workshop
was used to generate further priorities for evaluation.
Participants were split into small groups and asked to
reflect on the data from the survey and the reviews, and
to develop a priority list of interventions that would
potentially improve recruitment and could be subjected
to empirical testing. Groups reported back at the end of
their discussions on both the nature of those interventionsTable 1 Clinical Trials Unit survey on recruitment and retentio
evaluation)
Category Examples (recruitment)
Patient contact Patient information (appropriate design an
Promotion (newsletters, advertisements, pr
events, press release, and community sess
Patient convenience
Support for recruiters Presentations and training about recruitme
to recruiting staff
Monitoring and systems Recruitment staff reminders (computer po
Use of existing registers (mail shots and sc
Reducing burden (randomizing online in r
phone number for queries, and simple cas
Incentives Targets (site recruitment targets, feedback,
competition among sites)
Incentives (gifts for sites, co-authorship for
recruiters, and monetary incentives)
Design Relevance of study design
Piloting
Changing protocol (widening criteria)
Patient and public involvement
Resources Site resources
Additional resources (such as networks)
Human factors Relationships (face-to-face initiation visit, re
with recruitment staff, site champions, and
relationships between trials)and their priority order, and the results were categorized
by the workshop leader (PW). As the survey and work-
shop used professionals and involved discussions of
current practice, no formal ethical approval or consent
was deemed necessary.
Results
Responses were received from 23 individuals representing
18 CTUs (38%). Respondents included statisticians, trials
managers, health researchers, and research nurses.
Current recruitment and retention interventions
Table 1 shows the methods routinely used to encourage
recruitment and retention, which were coded into the
following categories: patient contact, patient conveni-
ence, support for recruiters, monitoring and systems,
incentives, design, resources, and human factors. These
broadly map onto the categories of recruitment inter-
ventions found in the recent Cochrane review discussed
previously [15].
Patient contact interventions in recruitment related to
appropriateness of the materials and the range of waysn - routinely used methods (with or without formal
Examples (retention)
d translation) Additional contacts (reminders, newsletters,
feedback for patients, and websites)
esentations,
ions)
Flexible appointments
Reducing research burden (shortened assessment
scales and online data collection)
nt issues Presentations and training about retention issues
to recruiting staff
p ups) Tracking patients (flagging, contacts for change
of address, and collection of multiple contacts)
reening notes) Reminders (calendars, alert cards, and ongoing
contacts with control or wait list participants)
eal-time,
e report forms)
and Incentives (gifts for sites, co-authorship for good
retention, and monetary incentives)
good
Options other than complete withdrawal
Patient and public involvement
gular contact
ongoing
Relationship (support for patient between visits,
handwriting envelopes, Christmas/birthday cards,
and thanking participants)
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more focused on the number of contacts with patients.
Both recruitment and retention interventions highlighted
ways of reducing burden on patients, although it is not
clear that research burden is necessarily the main barrier
to participation. A large number of systems and monitor-
ing interventions were discussed, to expand the range of
methods used to identify patients, and to enable partici-
pants to be identified in the longer term as the trial
progresses. Incentives included a wide range of potential
interventions, such as direct payment for recruiters,
patient expenses and gifts, and secondary incentives such
as authorship on papers for staff involved in recruitment.
Design issues were most often discussed in relation to
recruitment, and included initial appropriateness of the
design, the importance of pilot and feasibility studies, as
well as flexibility in response to difficulties of recruitment.
Respondents highlighted the importance of relationships
in both recruitment (with the focus on relationships be-
tween the research team and recruitment staff ) and reten-
tion (in terms of building and maintaining relationships
with patients).
Table 2 describes interventions felt to merit investiga-
tion by respondents, in three categories: training site
staff, communication with patients, and incentives. SomeTable 2 Clinical Trials Unit survey on recruitment and
retention - example methods thought to merit formal
evaluation
Category Examples
Training site staff Do site visits aid recruitment?
What is the impact of site and
investigator experience?
What is the effectiveness of computer
prompts?
What is the comparative effectiveness
of research nurses versus generic nurses?
What is the impact of patient and public
involvement?
Methods of communication
with patients
What is the effect of publications and
news releases?
What is the comparative effectiveness
of full information booklet versus a short
invitation letter?
What is the effect of telephone and/or
text appointment reminders?
What is the comparative cost efficacy of
radio advertisements versus newspapers?
What is the impact of patient and
public involvement?
Incentives Do small incentives (books or pens)
improve recruitment rates more than
acknowledgement in a newsletter or email?
What is the comparative effectiveness of
monetary incentives versus expenses?of these areas have been assessed in existing reviews, for
example, site visits and intensive communication have
been the subject of two studies with a published review,
with little demonstrable effect on recruitment [20]. It is
noteworthy that the impact of patient and public involve-
ment was raised in two themes, given recent observational
research suggesting an association between patient in-
volvement and recruitment success [24]. Although the use
of patient and public involvement is likely to be too em-
bedded in current research to test its impact compared
with an absence of involvement, exploring the relative
benefits of different types of patient involvement, or
different levels of resourcing of involvement is still likely
to be of benefit to the research community.
Priorities for evaluation - results from the workshop
The results from the CTUs survey were used to inform
a workshop on interventions to improve recruitment
and retention, using small group work to generate fur-
ther priorities for evaluation. Table 3 details the results
of the small group work. The top priority identified was
training for site staff, followed by different methods of
communication with patients. The following sections
provide more information about the potential priorities
within those areas that were generated at the workshop
and through follow-up teleconferences among workshop
participants.
Training site staff
Many trials involve direct communication between
patients and recruitment staff, and there is variability in
the ability of staff on the same trial to achieve high levels
of recruitment, with some studies reporting high levels
of recruitment from a minority of practitioners [25].
This may reflect factors other than differences in their
patient populations, such as variation among staff in the
perceived importance of the study question, or different
attitudes to equipoise. Identification of the characteris-
tics of staff associated with recruitment and retention
success could lead to a better selection of staff, while
comparison of staff with different levels of recruitment
success within the same trial might provide insights into
effective components of training which could be devel-
oped into relevant training packages prior to formal evalu-
ation. Such development will need to take into account
the current debates concerning the ethics around coer-
cive communication [26,27]. There is also an interesting
empirical question concerning the relationship between
strategies that enhance recruitment, and effects on
retention, as there is the possibility that encouraging
ambivalent patients into studies may lead to short-term
gains in recruitment, and longer term challenges in re-
tention. The need to evaluate different models of verbal
communication (for example empathic communication
Table 3 Priorities for evaluation from the workshop
Priority ranking Intervention Category
1 Training site staff and observation of recruitment Training site staff
2 Use of different media to convey information, for example video,
podcasts, and advertising
Methods of communication with patients
=3 Shifting information from the patient information leaflet to face-to-face discussion
=3 Patient preference for information
=3 Financial incentives for patients (need for public opinion on subject) Incentives
=3 Incentives for site the and/or site staff
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whether changes to recruiter communication behaviour
leads to benefits for patients beyond recruitment rates
(for example, improved satisfaction with the recruitment
process and perceptions of shared decision-making) were
also identified. Emphasis was placed on understanding
patient priorities at the time of recruitment and how
these may change over time to aid retention [28].
The relevant impact of generic communication skills
versus specific skills around particular issues is an
important issue. For example, discussions around patient
preferences are known to be a major potential barrier to
trial participation [29] and specific training in managing
those discussions might be more fruitful than generic
interventions, especially in certain contexts where pref-
erences are particularly important [28]. However, studies
continue to show problems in the core aspects of com-
munication [30]. Another important issue is whether
training should be provided at the start of any trial, for
all recruiters, or whether it is more feasible and efficient
to identify staff with low recruitment rates and intervene
later, potentially following detailed qualitative work to
identify the precise nature of the problems [31,32].
Methods of communication with patients
As noted, the focus of much of the discussion around
training site staff was around the issue of face-to-face
communication, whereas this theme related more to
different types and platforms for communication with
patients, and the balance between face-to-face discus-
sions, other forms of providing information to patients
[33], and wider interventions related to shared decision-
making [34]. The use of technology for communication
was highlighted in particular for recruitment in trials
where the initial recruitment is not via a face-to-face
consultation (such as community-based trials among
patients with existing conditions recruited initially by
postal or other methods). Technology was also consid-
ered to be an area that could assist with the retention of
participants over time, both through effective tracking
of patients and methods used to enhance motivation to
continue participation (such as reminders and updates
about trial progress).Given the dissatisfaction among patients and staff over
the potential length and burden associated with standard
patient information sheets, technology would also poten-
tially provide flexible and patient-centered methods to
provide information in appropriate depth according to
patient preference (as long as it meets minimum criteria
as set by ethical and regulatory bodies) [35].
Incentives
As noted in Tables 1 and 2, a wide range of potential in-
terventions acting as incentives are in use and of interest
to staff currently involved in the recruitment to trials,
but the evidence base is limited [10,21]. In relation to
patients, this may include payment for time taken to
participate (which might not be viewed formally as an
incentive, although it might have motivational benefits),
small gifts and payment for incidental expenses, as well
as formal cash or voucher incentives for participation
and retention. However, the scope for testing such
incentives through formal experimental methods may be
limited by ethical and equity considerations.
Issues of incentives can also be applied to professionals,
although the scope here may be greater, as potential in-
centives could be indirect (such as authorship on papers).
There may also be greater potential for experimental work
in the testing of the comparative effectiveness of schemes
which provide differential incentives for different recruit-
ment staff, teams, or sites depending on their relative
performance (per patient recruited incentives versus block
payments for meeting targets).
What is needed to facilitate rapid testing and
development of interventions?
Although there was agreement about the need to
conduct research on recruitment, the actual number of
recruitment interventions nested within existing trials is
very small [15]. Research has highlighted some of the
known barriers to undertaking such research [36] such
as increases in complexity, compatibility between the host
trial where the recruitment research is done and nested
trials (for example, the relevance of certain recruitment in-
terventions to certain patient populations), the impact of
nesting interventions on relationships with collaborators,
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resulting lack of equipoise), and concerns about appropri-
ate sample size.
Data on these issues were also collected from the
CTUs survey, and the results generally fell into three
categories. The first related to the logistics of running
nested studies, in terms of the extra resources required,
additional complications that might be caused to the
delivery of the host trial (such as regulatory delays), and
ethical barriers. The second barrier was a lack of perceived
equipoise around many proposed recruitment processes
and lack of enthusiasm in subjecting them to formal test-
ing. The third category related to scientific issues, includ-
ing concerns about the power to detect what might be
quite small effects from methodological innovations, and
the likely impact of variation in the effects of recruitment
interventions, in terms of their effects on different sites, in
different trials, and at different times.Discussion
Limitations of the study
The CTUs survey was limited by the 38% response rate,
and it is possible that non-responding units manage re-
cruitment and retention differently from those included
in the survey. Workshop participants (academics and
staff in CTUs) represent key stakeholders, but the views
of those attending a workshop on recruitment and
retention may not have been representative of the wider
trials community, and the findings would need confirm-
ation in other contexts. Importantly, different priorities
may be identified by other stakeholder groups, and in
different countries. Particularly, there is a need to replicate
these findings with patients and carers as core stake-
holders in recruitment and retention. In this study, the
CTUs survey was used to develop a list of recruitment
interventions to feed into discussions in the workshop,
but the content generated by the survey and the priorities
generated by the workshop were not formally triangulated
in any way.What are the limits to the impact of recruitment and
retention interventions?
As noted previously, a recent review outlined three core
areas of relevance to improving recruitment and retention:
infrastructure, stakeholder engagement with research, and
methodological innovation. In this paper, we have focused
on methodological innovation, which we believe has an
important part to play in improving recruitment and re-
tention performance, and has the advantage being able to
be evaluated and implemented throughout the platform of
current clinical trials in a rigorous and controlled manner.
Although the results are limited somewhat by the low
response rate and the potential for bias, they do give aunique indication of the views of CTUs currently involved
in recruitment and retention.
However, it is unclear how much variance in recruit-
ment and retention performance is due to technical issues
amenable to methodological research, compared to other
issues such as available infrastructure, the organization,
leadership, management and culture of research teams,
and attitudes and values within the wider community. For
example, staff in primary care networks in another work-
shop identified ‘positive attitudes of primary care staff
towards research’ and ‘trust of researchers by potential
participants’ as key contextual factors [37]. These factors
are not necessarily those that are the most amenable to
empirical testing, especially in a formal randomized
comparison, although there are relevant examples [38].
It is noteworthy that many of the issues felt by our
respondents to be worthy of evaluation are likely to have
relatively modest effects on recruitment or retention,
although this may reflect the fact that suggestions for
interventions of higher impact (such as incentives) may
be viewed as of low feasibility because of regulatory and
ethical barriers. The scientific benefits of modest impacts
on recruitment may be small (an increase in recruitment
rates from 10 to 15% may have little substantive effect
on external validity), although the benefits in terms of
logistics, time taken to recruit, and trial funding may still
be significant, given that the recruitment period may be
a key driver of the length of a trial and its overall cost.
Smaller benefits may be more important in retention.
It is possible that issues of efficiency are equally
important. For example, rather than adopting methods
with the aim of increasing the proportion of eligible
patients who participate, studies may focus on whether
more efficient methods can be adopted to maximize the
number of patients who can be approached (although
this is of course less relevant in certain contexts, such as
rarer diseases). For example, in primary care, many trials
have adopted postal recruitment using existing disease
registers in preference to traditional recruitment led by
clinicians [39]. The proportion of patients recruited by
such postal methods may be equal to or less than
traditional methods, but allows recruitment over a wider
geographical area whilst using the same resources.
A research agenda for recruitment and retention
interventions
The results of this survey and workshop raise a number
of implications for a future research agenda in this area.
Experienced trial staff may have implicit ideas about
what works in recruitment and retention, and a wide
variety of factors are thought to be relevant. Some of
these are likely to reflect good research practice and may
not need or warrant empirical testing. However, given
the importance of recruitment and the disruption it can
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needs to be tested to make recruitment practices more
evidence-based. Authors of systematic reviews have com-
mented that interventions that do get tested often bear an
uncertain relationship to those in the broader literature,
making pooled analyses difficult. We have highlighted
three core areas that were felt to be a suitable focus for
future work, and have considered some of the issues that
might be amenable to testing. Further advances in this
area may well be facilitated by the development and adop-
tion of frameworks and typologies of recruitment methods
of the type that have been adopted in other areas explor-
ing complex, behavioral interventions [40]. This would
involve describing categories of interventions and their
potential mechanisms of effect, as well as potential moder-
ating factors, such as the impact of different patient and
trial characteristics. As well as providing benefits in terms
of the development of effective interventions, this would
allow more effective pooling of analyses at the synthesis
stage.
Experienced trials personnel such as those involved in
the surveys and workshops may be used to dealing with
a lack of equipoise among clinical staff [41]. Therefore, it
is noteworthy that there is not always equipoise among
such staff about the effects of recruitment interventions,
which can potentially act as a barrier to their evaluation.
This raises the issue of how the delivery of nested re-
cruitment interventions can be better incentivized. For
example, individual trial teams and CTUs might receive
additional resources to support their attempts to nest
recruitment and retention studies in their trials to
increase the adoption of this approach.
Scientific objections to evaluations of recruitment and
retention interventions around issues such as power
and heterogeneity are reasonable, although effective
categorization, pooling, and meta-analysis could allow
for the testing and consideration of many of these issues.
The Medical Research Council Systematic Techniques for
Assisting Recruitment to Trials (MRC START) program
[42] and related initiatives such as Studies Within A Trial
(SWAT) [43] and TrialsForge [44] may encourage a
common framework across recruitment interventions
and pooling to provide a more precise estimate of their
effects, and to explore variation in their effects across
patient populations, trial types, and recruitment contexts.
Conclusions
Significant resources continue to be invested into
clinical trials, but recruitment and retention continue
to be problematic and remain high priorities among
CTUs in the United Kingdom. There continues to be a
major gap in the evidence base regarding what works
in recruitment and retention. These findings provide
guidance on areas that may be prioritized in thefunding of further methodological research in this
important area.
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